SCHEMBL2238428

SCHEMBL2238428

O=S(=O)(Cl)c1c(F)ccc(-c2ccccc2)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 6/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KAT6A Q92794 3/20 0.36
PTGS2 P35354 5/20 0.36
PTGS1 P23219 4/20 0.36
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
FABP4 P15090 1/20 0.35
FABP5 Q01469 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
FABP2 P12104 1/20 0.34
TSHR P16473 1/20 0.34
AKR1C4 P17516 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2C P28335 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27979836 0.82 CA12 (0.47) PTGS2PTGS1
SCHEMBL6291105 0.80 PKM (0.39) ACLYALDH1A1HSD17B10TDP1KAT6A
SCHEMBL7334530 0.80 PKM (0.39) ALDH1A1HSD17B10TDP1PTGS2PTGS1
SCHEMBL30986771 0.76 CA1 (0.39) ALDH1A1HSD17B10TDP1PTGS2PTGS1
SCHEMBL3523738 0.76 CA1 (0.39) ALDH1A1HSD17B10TDP1PTGS2PTGS1
SCHEMBL1685615 0.72 ALOX5AP (0.47) ALDH1A1HSD17B10PTGS2PTGS1ALOX5AP
SCHEMBL2324855 0.71 ALDH1A1 (0.47) ACLYALDH1A1HSD17B10TDP1PTGS2
SCHEMBL31454807 0.71 PKM (0.35) ALDH1A1HSD17B10TDP1PTGS2PTGS1
SCHEMBL10533047 0.71 ALOX5AP (0.53) ALDH1A1HSD17B10PTGS2PTGS1ALOX5AP
SCHEMBL28164099 0.70 CA12 (0.42) PTGS2PTGS1ALOX5APFEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
EP-2349990-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE Pimco 2664 Limited (GB) 2011-08-03 EP disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA ACLY 4094/4885ALDH1A1 1417/4885HSD17B10 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.